Wednesday, April 17, 2013

• Lorus Therapeutics Signs Research and License Option Agreement with ElancoMarketwired( (Wed, Apr 17)
• Lorus Therapeutics Signs Research and License Option Agreement With ElancoGlobeNewswire( (Wed, Apr 17)
• Lorus Therapeutics Signs Research and License Option Agreement with ElancoMarketwired( (Wed, Apr 17)

Friday, April 12, 2013

• Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2013Marketwired( (Fri, Apr 12)
• Lorus Therapeutics Reports Third Quarter Results for Fiscal Year 2013Marketwired( (Fri, Apr 12)

Wednesday, April 10, 2013

• Lorus Therapeutics Announces Presentation of Biomarker Data for LOR-253 at 2013 AACR Annual MeetingGlobeNewswire( (Wed, Apr 10)

Tuesday, March 5, 2013

• Lorus Therapeutics Announces Allowance of Chinese Patent for Anticancer Drug LOR-253Marketwired( (Tue, Mar 5)
• Lorus Therapeutics Announces Allowance of Chinese Patent for Anticancer Drug LOR-253Marketwired( (Tue, Mar 5)

Tuesday, February 12, 2013

• Lorus Therapeutics to Present LOR-253 Data at 2013 AACR Annual MeetingMarketwired( (Tue, Feb 12)
• Lorus Therapeutics to Present LOR-253 Data at 2013 AACR Annual MeetingMarketwired( (Tue, Feb 12)

Tuesday, January 22, 2013

• Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17EMarketwired( (Tue, Jan 22)
• Lorus Therapeutics Announces Issuance of United States Patent for Cancer Therapy IL-17EMarketwired( (Tue, Jan 22)

Monday, January 14, 2013

• Lorus Therapeutics Reports Second Quarter Results for Fiscal Year 2013Marketwired( (Mon, Jan 14)